CMV gB Antibodies

Santa Cruz Biotechnology offers a broad range of CMV gB Antibodies for research on cytomegalovirus glycoprotein B (gB). CMV gB Antibodies are compatible with multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cytomegalovirus gB plays a crucial role in viral entry and fusion, making it a key target for understanding CMV pathogenesis and developing therapeutic strategies. CMV gB is essential for viral infection of host cells and immune response evasion, highlighting its significance in both basic and applied research. Studying CMV gB can reveal important mechanisms of viral infection and host-pathogen interactions. Understanding CMV gB function is vital for developing antiviral treatments and preventive measures. Investigating CMV gB mechanisms provides insights into viral transmission and disease progression. Research using CMV gB can help identify potential therapeutic targets and intervention strategies. Santa Cruz Biotechnology monoclonal antibodies support the scientific community in advancing CMV research and developing innovative therapeutic approaches.